Oral Contraceptive Innovation Receives FDA Approval
Organon USAOrganon Inc. has received approval from the U.S. Food and Drug Administration to market MircetteË™ (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets, the first oral contraceptive to use a shortened hormone-free interval.